Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glycogen synthase kinase 3 alpha | Starlite/ChEMBL | References |
Homo sapiens | glycogen synthase kinase 3 beta | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0133 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0116 | 0.8708 | 1 |
Echinococcus granulosus | cathepsin b | 0.0133 | 1 | 1 |
Trypanosoma brucei | protein kinase, putative | 0.0116 | 0.8708 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0133 | 1 | 1 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0116 | 0.8708 | 1 |
Schistosoma mansoni | glycogen synthase kinase 3-related (gsk3) (cmgc group III) | 0.0116 | 0.8708 | 0.8708 |
Trypanosoma brucei | cysteine peptidase C (CPC) | 0.0044 | 0.3089 | 0.3547 |
Brugia malayi | intracellular kinase | 0.0116 | 0.8708 | 0.8708 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0116 | 0.8708 | 0.8708 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.8708 | 1 |
Echinococcus granulosus | protein kinase shaggy | 0.0116 | 0.8708 | 0.8708 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0133 | 1 | 1 |
Echinococcus multilocularis | glycogen synthase kinase 3 beta | 0.0116 | 0.8708 | 0.8708 |
Giardia lamblia | Kinase, CMGC GSK | 0.0116 | 0.8708 | 1 |
Toxoplasma gondii | cathepsin B | 0.0044 | 0.3089 | 0.3547 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.3089 | 0.3547 |
Trypanosoma cruzi | glycogen synthase kinase 3, putative | 0.0116 | 0.8708 | 0.8131 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.0044 | 0.3089 | 0.3547 |
Echinococcus granulosus | cathepsin b | 0.0133 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0133 | 1 | 1 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0133 | 1 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0133 | 1 | 1 |
Echinococcus multilocularis | protein kinase shaggy | 0.0116 | 0.8708 | 0.8708 |
Onchocerca volvulus | 0.0116 | 0.8708 | 1 | |
Plasmodium falciparum | glycogen synthase kinase 3 | 0.0116 | 0.8708 | 1 |
Loa Loa (eye worm) | CMGC/GSK protein kinase | 0.0116 | 0.8708 | 0.8708 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0116 | 0.8708 | 1 |
Leishmania major | glycogen synthase kinase, putative;with=GeneDB:LinJ18_V3.0270 | 0.0116 | 0.8708 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0116 | 0.8708 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 1 | 1 |
Loa Loa (eye worm) | cathepsin B | 0.0044 | 0.3089 | 0.3089 |
Treponema pallidum | cell division protein (ftsJ) | 0.0004 | 0 | 0.5 |
Toxoplasma gondii | cell-cycle-associated protein kinase GSK, putative | 0.0116 | 0.8708 | 1 |
Echinococcus multilocularis | cathepsin b | 0.0133 | 1 | 1 |
Echinococcus granulosus | glycogen synthase kinase 3 beta | 0.0116 | 0.8708 | 0.8708 |
Giardia lamblia | Kinase, CMGC GSK | 0.0116 | 0.8708 | 1 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0044 | 0.3089 | 0.3089 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.3089 | 0.3547 |
Giardia lamblia | Cathepsin B precursor | 0.0044 | 0.3089 | 0.3547 |
Plasmodium vivax | glycogen synthase kinase 3, putative | 0.0116 | 0.8708 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2697 nM | Inhibition of human glycogen synthase kinase-3alpha (hGSK-3) | ChEMBL. | 12699760 |
IC50 (binding) | = 2697 nM | Inhibition of recombinant GSK3beta (unknown origin) | ChEMBL. | 18324764 |
IC50 (binding) | = 2697 nM | Inhibition of human glycogen synthase kinase-3alpha (hGSK-3) | ChEMBL. | 12699760 |
IC50 (binding) | = 2697 nM | Inhibition of recombinant GSK3beta (unknown origin) | ChEMBL. | 18324764 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.